← Back to Search

Patient Empowerment Program for Prostate Cancer (PC-PEP Trial)

N/A
Recruiting
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >18
History of a prostate cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 - 24 months
Awards & highlights

PC-PEP Trial Summary

This trial aims to improve the quality of life for men with prostate cancer by testing a comprehensive intervention called the Prostate Cancer Patient Empowerment Program (PC-PEP).

Who is the study for?
This trial is for men over 18 with prostate cancer who can exercise moderately, use email and the internet, understand English, and are expected to live more than 2 years. They must be able to fill out surveys and watch videos online. Men unfit for low-level exercise or without internet access cannot join.Check my eligibility
What is being tested?
The Prostate Cancer Patient Empowerment Program (PC-PEP) is being tested on 400 men to improve their mental health, fitness levels, quality of life, and reduce side effects from treatments like surgery or radiation therapy.See study design
What are the potential side effects?
Since this program focuses on education and lifestyle changes rather than medication or medical procedures, it may not have typical clinical trial side effects but could include muscle soreness from increased physical activity.

PC-PEP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I have been diagnosed with prostate cancer.

PC-PEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 - 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 - 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mental Health
Secondary outcome measures
Diet as assessed by the Starting the Conversation (STC) Questionnaire
Disease Specific Health-Related Quality of Life as assessed by the Functional Assessment of Cancer Therapy-Prostate (FACT-P)
General Health (Physical and Mental) Quality of Life as assessed by the 12-item Short Form Health Survey (SF-12)
+5 more

PC-PEP Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
258 Previous Clinical Trials
83,354 Total Patients Enrolled
4 Trials studying Prostate Cancer
358 Patients Enrolled for Prostate Cancer

Media Library

Patient Empowerment Program Clinical Trial Eligibility Overview. Trial Name: NCT04895839 — N/A
Prostate Cancer Research Study Groups: Intervention Arm
Prostate Cancer Clinical Trial 2023: Patient Empowerment Program Highlights & Side Effects. Trial Name: NCT04895839 — N/A
Patient Empowerment Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04895839 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new subjects being admitted to this trial at present?

"Clinicaltrials.gov reflects that this experiment is actively seeking participants, which it began to do on September 29th 2021 and was last updated on December 7th 2021."

Answered by AI

What is the total sample size of this medical trial?

"That is correct. According to clinicaltrials.gov, this medical trial commenced on September 29th 2021 and has since been recruiting 500 patients from two sites."

Answered by AI
~177 spots leftby Sep 2025